Interestingly, RET mutations have been found in both multiple endocrine neoplasia type 2, characterized by medullary thyroid carcinoma (MTC), and primary colorectal cancer [98,99], supporting its oncogenic function in thyroid carcinoma and tumor-suppressing function in colon cancer, respectively. Here, RET is linked to colonic neoplasm.